HomeALXO • NASDAQ
add
ALX Oncology Holdings Inc
Previous close
$14.66
Day range
$14.13 - $14.68
Year range
$3.94 - $17.83
Market cap
740.34M USD
Avg Volume
621.98K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 37.76M | 17.26% |
Net income | -35.58M | -17.88% |
Net profit margin | — | — |
Earnings per share | -0.71 | 3.85% |
EBITDA | -37.55M | -17.37% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 157.44M | -30.93% |
Total assets | 212.65M | -23.55% |
Total liabilities | 48.46M | 28.36% |
Total equity | 164.20M | — |
Shares outstanding | 52.10M | — |
Price to book | 4.48 | — |
Return on assets | -41.48% | — |
Return on capital | -48.67% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -35.58M | -17.88% |
Cash from operations | -37.92M | -36.34% |
Cash from investing | 26.47M | -37.41% |
Cash from financing | 3.09M | 2,984.11% |
Net change in cash | -8.36M | -158.20% |
Free cash flow | -25.20M | -16.35% |
About
Founded
2015
Headquarters
Website
Employees
74